← back to search

Miquel Navasa

Instituto de Salud Carlos III · ES
Area of research
Hepatology · Surgery
Research interest
Research interests include Liver Disease and Transplantation, Organ Transplantation Techniques and Outcomes, Liver Disease Diagnosis and Treatment, and Hepatitis C virus research.
h-index
73
citations
22,037
works
348
NIH funding
primary concept
Medicine
email

Recent publications

Monitoring of Donor-Derived Cell-Free DNA by Short Tandem Repeats: Concentration of Total Cell-Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation.
2022cited by 25position: contributordoi
Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance.
2021cited by 5position: contributordoi
Author response: Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance
2021cited by 0position: contributordoi
MicroRNAs 155-5p, 122-5p, and 181a-5p Identify Patients With Graft Dysfunction Due to T Cell-Mediated Rejection After Liver Transplantation.
2020cited by 17position: contributordoi
Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients.
2020cited by 6position: contributordoi
Original and generic preservation solutions in organ transplantation. A new paradigm?
2020cited by 2position: contributordoi
Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients
Journal of Hepatology 2018cited by 61position: middledoi
Usefulness of liver stiffness measurement during acute cellular rejection in liver transplantation
Liver Transplantation 2015cited by 46position: lastdoi
HCV-Induced Immune Responses Influence the Development of Operational Tolerance After Liver Transplantation in Humans
Science Translational Medicine 2014cited by 85position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2020–2022)Xavier Forns · Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer4 papers (2014–2021)Alberto Sánchez‐Fueyo · King's College London3 papers (2014–2018)Rosa Miquel · Universidad de La Laguna3 papers (2014–2018)Carlos Benítez · Universitat de Barcelona2 papers (2014–2015)Jordi Colmenero · Hospital Clínic de Barcelona2 papers (2015–2020)Alan S. Perelson · Institute of Accelerating Systems and Applications2 papers (2021–2021)María‐Carlota Londoño · Centre for Biomedical Network Research on Rare Diseases2 papers (2014–2018)Antoni Rimola · Instituto de Salud Carlos III2 papers (2014–2018)Louis Shekhtman · Northeastern University2 papers (2021–2021)Susan L. Uprichard · Loyola University Medical Center2 papers (2021–2021)E. Fabian Cardozo-Ojeda · Xencor (United States)2 papers (2021–2021)Mercè Brunet · Institut d'Investigacions Biomèdiques August Pi i Sunyer2 papers (2020–2020) · 2 papers (2021–2021)Harel Dahari · Loyola University Chicago2 papers (2021–2021)Pablo Ruiz · Instituto de Salud Carlos III2 papers (2020–2020)Olga Millán · International Society for Optics and Photonics2 papers (2020–2020) · 2 papers (2021–2021)Sofía Pérez-del-Pulgar · Centro de Investigación Biomédica en Red2 papers (2021–2021)Juan José Lozano · Artistic Realization Technologies2 papers (2014–2018)